Breakpoint Therapeutics aims to advance the medical growth of first-in-class oncology medication that interfere with DNA repair and replication worry tolerance pathways. The corporate’s therapeutics target the DNA damage reaction in cancer cells with restore and replication stress tolerance pathways, enabling the professional medical organisation and hospitals to produce medication https://is.gd/VVmTMJ